The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
Stefan Kertesz, a physician and addiction expert, says overaggressive cutbacks can harm some chronic pain patients.
While Tapentadol is a serious habit-forming opioid-based drug, Pregabalin has become a headache in Punjab as it is ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...